Induction of Fas clustering and apoptosis by coral prostanoid in human hormone-resistant prostate cancer cells
Cyclopentenone prostaglandins (PGs) such as PGA 1, PGA 2 and Δ 12-PGJ 2 have been shown to suppress tumor cell growth and to induce apoptosis in prostate cancer cells. Bromovulone III, which is isolated from the soft coral Clavularia viridis, is a cyclopentenone prostanoid. In this study, the anti-t...
Gespeichert in:
Veröffentlicht in: | European journal of pharmacology 2006-08, Vol.542 (1), p.22-30 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 30 |
---|---|
container_issue | 1 |
container_start_page | 22 |
container_title | European journal of pharmacology |
container_volume | 542 |
creator | Chiang, Po-Cheng Kung, Fan-Lu Huang, Dong-Ming Li, Tsai-Kun Fan, Jia-Rong Pan, Shiow-Lin Shen, Ya-Ching Guh, Jih-Hwa |
description | Cyclopentenone prostaglandins (PGs) such as PGA
1, PGA
2 and Δ
12-PGJ
2 have been shown to suppress tumor cell growth and to induce apoptosis in prostate cancer cells. Bromovulone III, which is isolated from the soft coral
Clavularia viridis, is a cyclopentenone prostanoid. In this study, the anti-tumor activity as well as action mechanism of bromovulone III was identified in prostate cancer cells. Bromovulone III displayed anti-tumor activity of 30 to 100 times more effective than PGA
1, PGA
2 and Δ
12-PGJ
2 in PC-3 cells. Several targets of caspases and Bcl-2 family of proteins were detected and the data demonstrated that bromovulone III induced the activation of caspase-8, -9 and -3, and Bid cleavage in which the caspas-8 activation occurred the first. Bromovulone III did not modify the protein levels of death receptors and ligands. Of note, the Fas clustering in PC-3 cells responsive to bromovulone III was observed by confocal immunofluorescence microscopy suggesting the involvement of Fas-mediated pathway. Bromovulone III also induced the cleavage of Mcl-1 in this study. The cleavage fragments (24, 19 and 17 kDa) may partly share the apoptotic insult. Although it has been suggested that Fas-mediated signaling may contribute to the caspase-8 activation induced by DNA-damaging agents; however, bromovulone III did not induce any DNA breakage, suggesting that bromovulone III-induced Fas/caspase-8-dependent signaling is not through the direct target on DNA damage. In summary, the data suggest that bromovulone III causes a rapid redistribution and clustering of Fas in PC-3 cells. Subsequently, the Fas event causes the activation and interaction of caspase-8/Bid/caspase-9 signaling cascades, and the activation of executor caspase-3. |
doi_str_mv | 10.1016/j.ejphar.2006.05.030 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68671297</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0014299906005711</els_id><sourcerecordid>68671297</sourcerecordid><originalsourceid>FETCH-LOGICAL-c390t-d1d62ce3139178881e4a705b833b2648213f0709c479210bb50e995e4c781ad63</originalsourceid><addsrcrecordid>eNp9kM1q3TAQRkVoaW6TvkEp2rQ7uyPLP9KmUELTBgLdNGshS-NEF1tyJbmQt48u15BdNzOLOd_wcQj5yKBmwPqvxxqP65OOdQPQ19DVwOGCHJgYZAUDa96QAwBrq0ZKeUnep3QEgE423TtyyXoBPevkgfg7bzeTXfA0TPRWJ2rmLWWMzj9S7S3Va1hzSC7R8ZmaEPVM1xhS1j44S52nT9uiywxxCR6riAUtx7xTGanR3mCkBuc5XZO3k54Tftj3FXm4_fHn5ld1__vn3c33-8pwCbmyzPaNQc64ZIMQgmGrB-hGwfnY9K1oGJ9gAGnaQTYMxrEDlLLD1gyCadvzK_Ll_Le0-Lthympx6dRAewxbUr3oiyI5FLA9g6bUTREntUa36PisGKiTZ3VUZ8_q5FlBp4rnEvu0_9_GBe1raBdbgM87oJPR8xSLBJdeuUEWrOOF-3bmsNj45zCqZBwWYdZFNFnZ4P7f5AXFTJ4c</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68671297</pqid></control><display><type>article</type><title>Induction of Fas clustering and apoptosis by coral prostanoid in human hormone-resistant prostate cancer cells</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Chiang, Po-Cheng ; Kung, Fan-Lu ; Huang, Dong-Ming ; Li, Tsai-Kun ; Fan, Jia-Rong ; Pan, Shiow-Lin ; Shen, Ya-Ching ; Guh, Jih-Hwa</creator><creatorcontrib>Chiang, Po-Cheng ; Kung, Fan-Lu ; Huang, Dong-Ming ; Li, Tsai-Kun ; Fan, Jia-Rong ; Pan, Shiow-Lin ; Shen, Ya-Ching ; Guh, Jih-Hwa</creatorcontrib><description>Cyclopentenone prostaglandins (PGs) such as PGA
1, PGA
2 and Δ
12-PGJ
2 have been shown to suppress tumor cell growth and to induce apoptosis in prostate cancer cells. Bromovulone III, which is isolated from the soft coral
Clavularia viridis, is a cyclopentenone prostanoid. In this study, the anti-tumor activity as well as action mechanism of bromovulone III was identified in prostate cancer cells. Bromovulone III displayed anti-tumor activity of 30 to 100 times more effective than PGA
1, PGA
2 and Δ
12-PGJ
2 in PC-3 cells. Several targets of caspases and Bcl-2 family of proteins were detected and the data demonstrated that bromovulone III induced the activation of caspase-8, -9 and -3, and Bid cleavage in which the caspas-8 activation occurred the first. Bromovulone III did not modify the protein levels of death receptors and ligands. Of note, the Fas clustering in PC-3 cells responsive to bromovulone III was observed by confocal immunofluorescence microscopy suggesting the involvement of Fas-mediated pathway. Bromovulone III also induced the cleavage of Mcl-1 in this study. The cleavage fragments (24, 19 and 17 kDa) may partly share the apoptotic insult. Although it has been suggested that Fas-mediated signaling may contribute to the caspase-8 activation induced by DNA-damaging agents; however, bromovulone III did not induce any DNA breakage, suggesting that bromovulone III-induced Fas/caspase-8-dependent signaling is not through the direct target on DNA damage. In summary, the data suggest that bromovulone III causes a rapid redistribution and clustering of Fas in PC-3 cells. Subsequently, the Fas event causes the activation and interaction of caspase-8/Bid/caspase-9 signaling cascades, and the activation of executor caspase-3.</description><identifier>ISSN: 0014-2999</identifier><identifier>EISSN: 1879-0712</identifier><identifier>DOI: 10.1016/j.ejphar.2006.05.030</identifier><identifier>PMID: 16806159</identifier><identifier>CODEN: EJPHAZ</identifier><language>eng</language><publisher>Amsterdam: Elsevier B.V</publisher><subject>Animals ; Anthozoa - chemistry ; Antineoplastic Agents, Hormonal - pharmacology ; Apoptosis - drug effects ; Biological and medical sciences ; Blotting, Western ; Caspase 2 - metabolism ; Caspase Inhibitors ; Cell Cycle - drug effects ; Cell Line, Tumor ; Cell Proliferation - drug effects ; DNA Cleavage - drug effects ; DNA Fragmentation - drug effects ; Dose-Response Relationship, Drug ; Drug Resistance, Neoplasm ; Enzyme Activation - drug effects ; Fas clustering ; fas Receptor - metabolism ; Gynecology. Andrology. Obstetrics ; Humans ; Male ; Male genital diseases ; Mcl-1 cleavage ; Medical sciences ; Molecular Structure ; Nephrology. Urinary tract diseases ; Oligopeptides - pharmacology ; Pharmacology. Drug treatments ; Prostaglandin D2 - chemistry ; Prostaglandin D2 - pharmacology ; Prostaglandins - chemistry ; Prostaglandins - pharmacology ; Prostaglandins A - chemistry ; Prostaglandins A - pharmacology ; Prostanoid ; Prostate cancer ; Prostatic Neoplasms - drug therapy ; Prostatic Neoplasms - metabolism ; Prostatic Neoplasms - pathology ; Proto-Oncogene Proteins c-bcl-2 - metabolism ; Tumors ; Tumors of the urinary system ; Urinary tract. Prostate gland</subject><ispartof>European journal of pharmacology, 2006-08, Vol.542 (1), p.22-30</ispartof><rights>2006 Elsevier B.V.</rights><rights>2006 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c390t-d1d62ce3139178881e4a705b833b2648213f0709c479210bb50e995e4c781ad63</citedby><cites>FETCH-LOGICAL-c390t-d1d62ce3139178881e4a705b833b2648213f0709c479210bb50e995e4c781ad63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ejphar.2006.05.030$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=17961553$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16806159$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chiang, Po-Cheng</creatorcontrib><creatorcontrib>Kung, Fan-Lu</creatorcontrib><creatorcontrib>Huang, Dong-Ming</creatorcontrib><creatorcontrib>Li, Tsai-Kun</creatorcontrib><creatorcontrib>Fan, Jia-Rong</creatorcontrib><creatorcontrib>Pan, Shiow-Lin</creatorcontrib><creatorcontrib>Shen, Ya-Ching</creatorcontrib><creatorcontrib>Guh, Jih-Hwa</creatorcontrib><title>Induction of Fas clustering and apoptosis by coral prostanoid in human hormone-resistant prostate cancer cells</title><title>European journal of pharmacology</title><addtitle>Eur J Pharmacol</addtitle><description>Cyclopentenone prostaglandins (PGs) such as PGA
1, PGA
2 and Δ
12-PGJ
2 have been shown to suppress tumor cell growth and to induce apoptosis in prostate cancer cells. Bromovulone III, which is isolated from the soft coral
Clavularia viridis, is a cyclopentenone prostanoid. In this study, the anti-tumor activity as well as action mechanism of bromovulone III was identified in prostate cancer cells. Bromovulone III displayed anti-tumor activity of 30 to 100 times more effective than PGA
1, PGA
2 and Δ
12-PGJ
2 in PC-3 cells. Several targets of caspases and Bcl-2 family of proteins were detected and the data demonstrated that bromovulone III induced the activation of caspase-8, -9 and -3, and Bid cleavage in which the caspas-8 activation occurred the first. Bromovulone III did not modify the protein levels of death receptors and ligands. Of note, the Fas clustering in PC-3 cells responsive to bromovulone III was observed by confocal immunofluorescence microscopy suggesting the involvement of Fas-mediated pathway. Bromovulone III also induced the cleavage of Mcl-1 in this study. The cleavage fragments (24, 19 and 17 kDa) may partly share the apoptotic insult. Although it has been suggested that Fas-mediated signaling may contribute to the caspase-8 activation induced by DNA-damaging agents; however, bromovulone III did not induce any DNA breakage, suggesting that bromovulone III-induced Fas/caspase-8-dependent signaling is not through the direct target on DNA damage. In summary, the data suggest that bromovulone III causes a rapid redistribution and clustering of Fas in PC-3 cells. Subsequently, the Fas event causes the activation and interaction of caspase-8/Bid/caspase-9 signaling cascades, and the activation of executor caspase-3.</description><subject>Animals</subject><subject>Anthozoa - chemistry</subject><subject>Antineoplastic Agents, Hormonal - pharmacology</subject><subject>Apoptosis - drug effects</subject><subject>Biological and medical sciences</subject><subject>Blotting, Western</subject><subject>Caspase 2 - metabolism</subject><subject>Caspase Inhibitors</subject><subject>Cell Cycle - drug effects</subject><subject>Cell Line, Tumor</subject><subject>Cell Proliferation - drug effects</subject><subject>DNA Cleavage - drug effects</subject><subject>DNA Fragmentation - drug effects</subject><subject>Dose-Response Relationship, Drug</subject><subject>Drug Resistance, Neoplasm</subject><subject>Enzyme Activation - drug effects</subject><subject>Fas clustering</subject><subject>fas Receptor - metabolism</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Humans</subject><subject>Male</subject><subject>Male genital diseases</subject><subject>Mcl-1 cleavage</subject><subject>Medical sciences</subject><subject>Molecular Structure</subject><subject>Nephrology. Urinary tract diseases</subject><subject>Oligopeptides - pharmacology</subject><subject>Pharmacology. Drug treatments</subject><subject>Prostaglandin D2 - chemistry</subject><subject>Prostaglandin D2 - pharmacology</subject><subject>Prostaglandins - chemistry</subject><subject>Prostaglandins - pharmacology</subject><subject>Prostaglandins A - chemistry</subject><subject>Prostaglandins A - pharmacology</subject><subject>Prostanoid</subject><subject>Prostate cancer</subject><subject>Prostatic Neoplasms - drug therapy</subject><subject>Prostatic Neoplasms - metabolism</subject><subject>Prostatic Neoplasms - pathology</subject><subject>Proto-Oncogene Proteins c-bcl-2 - metabolism</subject><subject>Tumors</subject><subject>Tumors of the urinary system</subject><subject>Urinary tract. Prostate gland</subject><issn>0014-2999</issn><issn>1879-0712</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kM1q3TAQRkVoaW6TvkEp2rQ7uyPLP9KmUELTBgLdNGshS-NEF1tyJbmQt48u15BdNzOLOd_wcQj5yKBmwPqvxxqP65OOdQPQ19DVwOGCHJgYZAUDa96QAwBrq0ZKeUnep3QEgE423TtyyXoBPevkgfg7bzeTXfA0TPRWJ2rmLWWMzj9S7S3Va1hzSC7R8ZmaEPVM1xhS1j44S52nT9uiywxxCR6riAUtx7xTGanR3mCkBuc5XZO3k54Tftj3FXm4_fHn5ld1__vn3c33-8pwCbmyzPaNQc64ZIMQgmGrB-hGwfnY9K1oGJ9gAGnaQTYMxrEDlLLD1gyCadvzK_Ll_Le0-Lthympx6dRAewxbUr3oiyI5FLA9g6bUTREntUa36PisGKiTZ3VUZ8_q5FlBp4rnEvu0_9_GBe1raBdbgM87oJPR8xSLBJdeuUEWrOOF-3bmsNj45zCqZBwWYdZFNFnZ4P7f5AXFTJ4c</recordid><startdate>20060807</startdate><enddate>20060807</enddate><creator>Chiang, Po-Cheng</creator><creator>Kung, Fan-Lu</creator><creator>Huang, Dong-Ming</creator><creator>Li, Tsai-Kun</creator><creator>Fan, Jia-Rong</creator><creator>Pan, Shiow-Lin</creator><creator>Shen, Ya-Ching</creator><creator>Guh, Jih-Hwa</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20060807</creationdate><title>Induction of Fas clustering and apoptosis by coral prostanoid in human hormone-resistant prostate cancer cells</title><author>Chiang, Po-Cheng ; Kung, Fan-Lu ; Huang, Dong-Ming ; Li, Tsai-Kun ; Fan, Jia-Rong ; Pan, Shiow-Lin ; Shen, Ya-Ching ; Guh, Jih-Hwa</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c390t-d1d62ce3139178881e4a705b833b2648213f0709c479210bb50e995e4c781ad63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Animals</topic><topic>Anthozoa - chemistry</topic><topic>Antineoplastic Agents, Hormonal - pharmacology</topic><topic>Apoptosis - drug effects</topic><topic>Biological and medical sciences</topic><topic>Blotting, Western</topic><topic>Caspase 2 - metabolism</topic><topic>Caspase Inhibitors</topic><topic>Cell Cycle - drug effects</topic><topic>Cell Line, Tumor</topic><topic>Cell Proliferation - drug effects</topic><topic>DNA Cleavage - drug effects</topic><topic>DNA Fragmentation - drug effects</topic><topic>Dose-Response Relationship, Drug</topic><topic>Drug Resistance, Neoplasm</topic><topic>Enzyme Activation - drug effects</topic><topic>Fas clustering</topic><topic>fas Receptor - metabolism</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Humans</topic><topic>Male</topic><topic>Male genital diseases</topic><topic>Mcl-1 cleavage</topic><topic>Medical sciences</topic><topic>Molecular Structure</topic><topic>Nephrology. Urinary tract diseases</topic><topic>Oligopeptides - pharmacology</topic><topic>Pharmacology. Drug treatments</topic><topic>Prostaglandin D2 - chemistry</topic><topic>Prostaglandin D2 - pharmacology</topic><topic>Prostaglandins - chemistry</topic><topic>Prostaglandins - pharmacology</topic><topic>Prostaglandins A - chemistry</topic><topic>Prostaglandins A - pharmacology</topic><topic>Prostanoid</topic><topic>Prostate cancer</topic><topic>Prostatic Neoplasms - drug therapy</topic><topic>Prostatic Neoplasms - metabolism</topic><topic>Prostatic Neoplasms - pathology</topic><topic>Proto-Oncogene Proteins c-bcl-2 - metabolism</topic><topic>Tumors</topic><topic>Tumors of the urinary system</topic><topic>Urinary tract. Prostate gland</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chiang, Po-Cheng</creatorcontrib><creatorcontrib>Kung, Fan-Lu</creatorcontrib><creatorcontrib>Huang, Dong-Ming</creatorcontrib><creatorcontrib>Li, Tsai-Kun</creatorcontrib><creatorcontrib>Fan, Jia-Rong</creatorcontrib><creatorcontrib>Pan, Shiow-Lin</creatorcontrib><creatorcontrib>Shen, Ya-Ching</creatorcontrib><creatorcontrib>Guh, Jih-Hwa</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chiang, Po-Cheng</au><au>Kung, Fan-Lu</au><au>Huang, Dong-Ming</au><au>Li, Tsai-Kun</au><au>Fan, Jia-Rong</au><au>Pan, Shiow-Lin</au><au>Shen, Ya-Ching</au><au>Guh, Jih-Hwa</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Induction of Fas clustering and apoptosis by coral prostanoid in human hormone-resistant prostate cancer cells</atitle><jtitle>European journal of pharmacology</jtitle><addtitle>Eur J Pharmacol</addtitle><date>2006-08-07</date><risdate>2006</risdate><volume>542</volume><issue>1</issue><spage>22</spage><epage>30</epage><pages>22-30</pages><issn>0014-2999</issn><eissn>1879-0712</eissn><coden>EJPHAZ</coden><abstract>Cyclopentenone prostaglandins (PGs) such as PGA
1, PGA
2 and Δ
12-PGJ
2 have been shown to suppress tumor cell growth and to induce apoptosis in prostate cancer cells. Bromovulone III, which is isolated from the soft coral
Clavularia viridis, is a cyclopentenone prostanoid. In this study, the anti-tumor activity as well as action mechanism of bromovulone III was identified in prostate cancer cells. Bromovulone III displayed anti-tumor activity of 30 to 100 times more effective than PGA
1, PGA
2 and Δ
12-PGJ
2 in PC-3 cells. Several targets of caspases and Bcl-2 family of proteins were detected and the data demonstrated that bromovulone III induced the activation of caspase-8, -9 and -3, and Bid cleavage in which the caspas-8 activation occurred the first. Bromovulone III did not modify the protein levels of death receptors and ligands. Of note, the Fas clustering in PC-3 cells responsive to bromovulone III was observed by confocal immunofluorescence microscopy suggesting the involvement of Fas-mediated pathway. Bromovulone III also induced the cleavage of Mcl-1 in this study. The cleavage fragments (24, 19 and 17 kDa) may partly share the apoptotic insult. Although it has been suggested that Fas-mediated signaling may contribute to the caspase-8 activation induced by DNA-damaging agents; however, bromovulone III did not induce any DNA breakage, suggesting that bromovulone III-induced Fas/caspase-8-dependent signaling is not through the direct target on DNA damage. In summary, the data suggest that bromovulone III causes a rapid redistribution and clustering of Fas in PC-3 cells. Subsequently, the Fas event causes the activation and interaction of caspase-8/Bid/caspase-9 signaling cascades, and the activation of executor caspase-3.</abstract><cop>Amsterdam</cop><pub>Elsevier B.V</pub><pmid>16806159</pmid><doi>10.1016/j.ejphar.2006.05.030</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0014-2999 |
ispartof | European journal of pharmacology, 2006-08, Vol.542 (1), p.22-30 |
issn | 0014-2999 1879-0712 |
language | eng |
recordid | cdi_proquest_miscellaneous_68671297 |
source | MEDLINE; Elsevier ScienceDirect Journals Complete |
subjects | Animals Anthozoa - chemistry Antineoplastic Agents, Hormonal - pharmacology Apoptosis - drug effects Biological and medical sciences Blotting, Western Caspase 2 - metabolism Caspase Inhibitors Cell Cycle - drug effects Cell Line, Tumor Cell Proliferation - drug effects DNA Cleavage - drug effects DNA Fragmentation - drug effects Dose-Response Relationship, Drug Drug Resistance, Neoplasm Enzyme Activation - drug effects Fas clustering fas Receptor - metabolism Gynecology. Andrology. Obstetrics Humans Male Male genital diseases Mcl-1 cleavage Medical sciences Molecular Structure Nephrology. Urinary tract diseases Oligopeptides - pharmacology Pharmacology. Drug treatments Prostaglandin D2 - chemistry Prostaglandin D2 - pharmacology Prostaglandins - chemistry Prostaglandins - pharmacology Prostaglandins A - chemistry Prostaglandins A - pharmacology Prostanoid Prostate cancer Prostatic Neoplasms - drug therapy Prostatic Neoplasms - metabolism Prostatic Neoplasms - pathology Proto-Oncogene Proteins c-bcl-2 - metabolism Tumors Tumors of the urinary system Urinary tract. Prostate gland |
title | Induction of Fas clustering and apoptosis by coral prostanoid in human hormone-resistant prostate cancer cells |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T07%3A55%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Induction%20of%20Fas%20clustering%20and%20apoptosis%20by%20coral%20prostanoid%20in%20human%20hormone-resistant%20prostate%20cancer%20cells&rft.jtitle=European%20journal%20of%20pharmacology&rft.au=Chiang,%20Po-Cheng&rft.date=2006-08-07&rft.volume=542&rft.issue=1&rft.spage=22&rft.epage=30&rft.pages=22-30&rft.issn=0014-2999&rft.eissn=1879-0712&rft.coden=EJPHAZ&rft_id=info:doi/10.1016/j.ejphar.2006.05.030&rft_dat=%3Cproquest_cross%3E68671297%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=68671297&rft_id=info:pmid/16806159&rft_els_id=S0014299906005711&rfr_iscdi=true |